Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Törnebohm

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Haematology|March 1, 1993
A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972-1991E Törnebohm, D Lockner, C Paul
Lakartidningen|March 31, 1993
[An inquiry on medical teaching. Pedagogic qualifications are important]D Mårtenson, U Broomé, V Strand, et al.
Haemostasis|January 1, 1992
Elastase activity in leukemic cellsE Törnebohm, D Lockner, C Paul, et al.
Acta Medica Scandinavica|January 1, 1987
Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferonD Lockner, G Bratt, A Lindborg, et al.
Haemostasis|January 1, 1986
Pharmacokinetics of intravenously and subcutaneously administered Fragmin in healthy volunteersD Lockner, G Bratt, E Törnebohm, et al.
Thrombosis and Haemostasis|April 22, 1985
A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragmentG Bratt, E Törnebohm, D Lockner, et al.
Thrombosis Research|June 1, 1986
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersG Bratt, E Törnebohm, L Widlund, et al.
Haemostasis|January 1, 1986
Intravenous and subcutaneous administration of Fragmin in deep venous thrombosisD Lockner, G Bratt, E Törnebohm, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2aM Merup, E Törnebohm-Roche, K Engman, et al.
American Journal of Hematology|March 1, 1995
Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosisE Törnebohm-Roche, M Merup, D Lockner, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Haematology|March 1, 1993
A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972-1991E Törnebohm, D Lockner, C Paul
Lakartidningen|March 31, 1993
[An inquiry on medical teaching. Pedagogic qualifications are important]D Mårtenson, U Broomé, V Strand, et al.
Haemostasis|January 1, 1992
Elastase activity in leukemic cellsE Törnebohm, D Lockner, C Paul, et al.
Acta Medica Scandinavica|January 1, 1987
Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferonD Lockner, G Bratt, A Lindborg, et al.
Haemostasis|January 1, 1986
Pharmacokinetics of intravenously and subcutaneously administered Fragmin in healthy volunteersD Lockner, G Bratt, E Törnebohm, et al.
Thrombosis and Haemostasis|April 22, 1985
A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragmentG Bratt, E Törnebohm, D Lockner, et al.
Thrombosis Research|June 1, 1986
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersG Bratt, E Törnebohm, L Widlund, et al.
Haemostasis|January 1, 1986
Intravenous and subcutaneous administration of Fragmin in deep venous thrombosisD Lockner, G Bratt, E Törnebohm, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2aM Merup, E Törnebohm-Roche, K Engman, et al.
American Journal of Hematology|March 1, 1995
Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosisE Törnebohm-Roche, M Merup, D Lockner, et al.
Pageof 2